HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tal I Arnon Selected Research

Immunoglobulin G (IgG)

5/2008Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tal I Arnon Research Topics

Disease

9Neoplasms (Cancer)
01/2015 - 01/2004
2Infections
09/2011 - 05/2006
2Human Influenza (Influenza)
05/2006 - 01/2004
2Melanoma (Melanoma, Malignant)
08/2004 - 03/2002
1Hyperplasia
05/2008
1Prostatic Neoplasms (Prostate Cancer)
05/2008
1Virus Diseases (Viral Diseases)
06/2006
1Ankylosing Spondylitis
07/2005
1Carcinoma (Carcinomatosis)
06/2005

Drug/Important Bio-Agent (IBA)

3LigandsIBA
05/2008 - 03/2002
3Proteins (Proteins, Gene)FDA Link
05/2008 - 03/2002
2AntigensIBA
09/2011 - 10/2006
2Histocompatibility Antigens Class IIBA
06/2006 - 08/2004
1Immunoglobulin G (IgG)IBA
05/2008
1Natural Killer Cell ReceptorsIBA
05/2006
1Green Fluorescent ProteinsIBA
05/2006
1HLA-B27 Antigen (HLA B27 Antigen)IBA
07/2005
1Tumor Biomarkers (Tumor Markers)IBA
06/2005
1human CD99 proteinIBA
07/2004
1CEACAM1 ProteinIBA
03/2004
1Hemagglutinins (Hemagglutinin)IBA
01/2004
1Viral HemagglutininsIBA
01/2004

Therapy/Procedure

2Therapeutics
01/2015 - 05/2008